Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 209,893,638 papers from all fields of science
Search
Sign In
Create Free Account
Gallium Ga 68 OPS202
Known as:
68Ga-OPS202
A radioconjugate consisting of the somatostatin antagonistic peptide OPS202 that is labeled with the positron-emitting radionuclide gallium Ga 68…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Somatostatin Receptor Antagonists for Imaging and Therapy
M. Fani
,
G. Nicolas
,
D. Wild
Journal of Nuclear Medicine
2017
Corpus ID: 9480322
Somatostatin receptor (sstr) scintigraphy for imaging and sstr analogs for treatment have been used for more than 20 y. An…
Expand
Highly Cited
2017
Highly Cited
2017
Sensitivity Comparison of 68Ga-OPS202 and 68Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study
G. Nicolas
,
N. Schreiter
,
+8 authors
D. Wild
Journal of Nuclear Medicine
2017
Corpus ID: 40521791
Radiolabeled somatostatin (sst) receptor agonists are integral to the diagnosis of gastroenteropancreatic neuroendocrine tumors…
Expand
Highly Cited
2017
Highly Cited
2017
Safety, Biodistribution, and Radiation Dosimetry of 68Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study
G. Nicolas
,
S. Beykan
,
+8 authors
D. Wild
Journal of Nuclear Medicine
2017
Corpus ID: 207408917
Preclinical and preliminary clinical evidence indicates that radiolabeled somatostatin (sst) receptor antagonists perform better…
Expand
2017
2017
Theranostic trial of well differentiated neuroendocrine tumors (NETs) with somatostatin antagonists 68Ga-OPS202 and 177Lu-OPS201.
D. Reidy
,
N. Pandit-Taskar
,
+7 authors
W. Weber
2017
Corpus ID: 79809693
4094Background: Radiolabeled somatostatin receptor 2 (sstr2) antagonists have shown higher tumor uptake and tumor-to-organ ratios…
Expand
2016
2016
PET/CT with the somatostatin receptor antagonist 68Ga-OPS202 is twice as accurate as with the agonist 68Ga-DOTATOC for detecting liver metastases: Results of a phase 1/2 study in…
G. Nicolas
,
N. Schreiter
,
+6 authors
D. Wild
2016
Corpus ID: 78422008
2015
2015
First clinical data on 68Ga-labeled somatostatin receptor antagonists: a phase I/II study comparing 68Ga-OPS202 with 68Ga-DOTATOC PET/CT.
G. Nicolas
,
F. Kaul
,
R. Mena
,
H. Bouterfa
,
M. Fani
,
D. Wild
2015
Corpus ID: 75299917
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE